Jasper Therapeutics
Briquilimab, a monoclonal antibody targeting cKIT for non-myeloablative conditioning in stem cell transplantation
- Sector
- Biotech
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 40 pending
Capital timeline
No federal awards or Form D filings are on record for this company.
Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.
Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards
Founder? Add funding contextFounders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 40- PendingTransgenic Animals Expressing Chimeric C-kit ProteinUSPTOApplication 19103734
- PendingCompositions And Methods For Depletion Of Diseased Hematopoietic Stem CellsUSPTOApplication 18841051
- PendingModified Stem Cell Compositions And Methods For UseUSPTOApplication 18702078
Show all 40 patent records
- Transgenic Animals Expressing Chimeric C-kit ProteinFeb 26, 2026 · Application 19103734Pending
- Compositions And Methods For Depletion Of Diseased Hematopoietic Stem CellsMay 29, 2025 · Application 18841051Pending
- Modified Stem Cell Compositions And Methods For UseDec 12, 2024 · Application 18702078Pending
- Modified Stem Cell Compositions And Methods For UseApr 11, 2024 · Application 18276325Pending
- Compositions And Methods For Stem Cell Transplant Conditioning And Uses ThereofJun 15, 2023 · Application 18047604Pending
- Compositions And Methods For Depletion Of Mast CellsApplication 63649158Pending
- Compositions And Methods For Depletion Of Mast CellsApplication 63645821Pending
- Methods Of Treatment Using ANTI-CD117 (FAB')2Application 63645820Pending
- Compositions And Methods For Depletion Of Mast CellsApplication 63555780Pending
- Modified Stem Cell Compositions And Methods For UseApplication PCTUS2024015853Pending
- Modified Stem Cell Compositions And Methods For UseApplication PCTUS2024015850Pending
- Methods For The Prevention And Treatment Of GvhdApplication PCTUS2024011187Pending
- Compositions And Methods For Treating Chronic UrticariaApplication 63604178Pending
- Modified Stem Cell Compositions And Methods For UseApplication 63593911Pending
- Modified Stem Cell Compositions And Methods For UseApplication 63593909Pending
- Methods For The Prevention And Treatment Of GvhdApplication 63593901Pending
- Methods Of Treatment Using ANTI-CD117 (FAB')2Application 63543245Pending
- Compositions And Methods For Depletion Of Mast CellsApplication 63543215Pending
- Transgenic Animals Expressing Chimeric C-kit ProteinApplication PCTUS2023072253Pending
- Modified Stem Cell Compositions And Methods For UseApplication PCTUS2023071937Pending
- Modified Stem Cell Compositions And Methods For UseApplication PCTUS2023067433Pending
- Methods For Treating Mast Cell Disorders With ANTI-CD117 AntibodiesApplication PCTUS2026010499Pending
- Methods For Treating Mast Cell Disorders With ANTI-CD117 AntibodiesApplication 63755855Pending
- Methods for Treating Mast Cell Disorders with Anti-CD117 AntibodiesApplication 63742811Pending
- Compositions And Methods For Depletion Of Diseased Hematopoietic Stem CellsApplication PCTUS2023014175Pending
- Modified Stem Cell Compositions And Methods For UseApplication 63485231Pending
- Modified Stem Cell Compositions And Methods For UseApplication 63485195Pending
- Modified Stem Cell Compositions And Methods For UseApplication 63485249Pending
- Modified Stem Cell Compositions And Methods For UseApplication 63485184Pending
- Methods For The Prevention And Treatment Of GvhdApplication 63438762Pending
- Modified Stem Cell Compositions And Methods For UseApplication PCTUS2022078320Pending
- Transgenic Animals Expressing Chimeric C-kit ProteinApplication 63371489Pending
- Modified Stem Cell Compositions And Methods For UseApplication PCTUS2022074942Pending
- Modified Stem Cell Compositions And Methods For UseApplication 63396912Pending
- Modified Stem Cell Compositions And Methods For UseApplication 63345667Pending
- Compositions And Methods For Stem Cell Transplant Conditioning And Uses ThereofApplication 63334602Pending
- Compositions And Methods For Stem Cell Transplant Conditioning And Uses ThereofApplication 63314923Pending
- Compositions And Methods For Selective Depletion Of Diseased Hematopoietic Stem CellsApplication 63314917Pending
- Modified Stem Cell Compositions And Methods For UseApplication 63314942Pending
- Modified Stem Cell Compositions And Methods For UseApplication PCTUS2022015861Pending
Related companies, and why
- CRYPTYX BIOSCIENCE, INC.Similar federal contract value in Biotech · null in contracts
- MAMMAE BIOSCIENCES, INC.Similar federal contract value in Biotech · null in contracts
- MS BIOTEC, LLCSimilar federal contract value in Biotech · null in contracts
- TERP LIFE, LLCSimilar federal contract value in Biotech · null in contracts
- ENRECTEC LLCSimilar federal contract value in Biotech · null in contracts
- COGTHERA, LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .